Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pelvic Neoplasms 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Rectal Neoplasms 1Mesothelioma 1Malignant Solid Neoplasm 1Lung Neoplasms 1Leiomyoma 1Colonic Polyps 1Colonic Neoplasms 1Chylous Ascites 1Carcinoma, Non-Small-Cell Lung 1Adenomyosis 1Abdominal Neoplasms 1

Interventions

Fluorouracil 267Oxaliplatin 266Capecitabine 224Leucovorin 209Irinotecan 151Radiotherapy 131Bevacizumab 112Cetuximab 81Folfox protocol 48Surgical Procedures, Operative 44Radiation 41Drug Therapy 41Neoadjuvant Therapy 40Chemoradiotherapy 33Chemotherapy, Adjuvant 32Panitumumab 27XELOX 25Magnetic Resonance Spectroscopy 22Radiotherapy, Intensity-Modulated 21Floxuridine 17Biopsy 16Nivolumab 15Gemcitabine 15Early Intervention, Educational 15pembrolizumab 14Laparoscopy 14IFL protocol 14Celecoxib 14trifluridine tipiracil drug combination 13Gene Expression Profiling 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Rectal Neoplasms × Iohexol × Clear all
NCT00576563 2016-04-21

Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer

Maastricht Radiation Oncology

Phase NA Completed
103 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡